Skip to content

A study to compare the effect of two ayurvedic medicines and ayurvedic lepa in the management of melasama.

A Clinico-Comparative Study To Evaluate The Efficacy Of Varnya Mahakashaya Ghanvati With Raktachandanadi Lepa And Laghu Manjisthadi Kwath Ghanvati With Raktachandanadi Lepa In The Management Of Vyanga With Special Reference To Melasma - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091770
Enrollment
40
Registered
2025-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Sponsors

pt khushilal sharma govt autonomous ayurveda college and institue bhopal mp
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the criteria of Vyanga presenting with clinical symptoms of Vyanga Patient of either sex will be selected irrespective of cast religion occupation habitat etc Patient who are willing to give written consent for study and photography

Exclusion criteria

Exclusion criteria: Patient having other skin disease like Psoriasis Atopic dermatitis SLE Systemic lupus erythematosus leprosy etc Pregnant and Lactating Women Patients with history of any drug allergies Patient taking steroids or hormonal therapy Patients who have any Immunocompressive diseases like HIV Cancer

Design outcomes

Primary

MeasureTime frame
It is expected that at the end of the study we would be able to evaluate and compare the outcome of Varnya Mahakashaya Ghanvati with Raktachandanadi Lepa and Laghu Manjisthadi kwath ghanvati with Raktachandanadi Lepa in the management of VyangaTimepoint: 12 months

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Deepak Rathor

pt. khushilal sharma govt autonomous ayurveda college and institue bhopal mp

drshraddha.sharma@yahoo.com8109352934

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026